MME and hydrops fetalis: Despite the availability of pharmacological treatments for cardiac remodeling and HF, including newly recommended angiotensin receptor/neprilysin inhibitors, sodium-glucose cotransporter-2 inhibitors, and vericiguat, the long-term prognosis remains bleak [21].